Stealth liberal tax group blasts Pfizer, urges stop to its tax-cutting deal

[Leroy N. Soetoro]

http://www.miamiherald.com/news/article62422747.html

A consumer group is accusing Pfizer of seeking to avoid $35 billion in
U.S. taxes with its plan to buy fellow drugmaker Allergan in a deal
structured to nominally move Pfizer's address to lower-tax Ireland,
Allergan's home.

In a report released Thursday, Americans for Taxpayer Fairness says that
would also slash future U.S. taxes paid by Pfizer Inc., which will keep
its operational headquarters at its New York City base. Pfizer would still
have to pay U.S. taxes on income earned in the country, but not overseas.

The group has been urging federal regulation changes to block not just the
Pfizer deal, but a surge of other companies in various industries doing
inversions to slash their U.S. tax bills. That lost revenue ultimately
comes out of the pockets of consumers and other taxpayers.

Americans for Taxpayer Fairness also accuses Pfizer of gouging Americans
with frequent and excessive price hikes on its medicines while benefiting
from multiple loopholes and tax deductions that reduce Pfizer's U.S. tax
rate, on average, to 6.4 percent. That's well below the 24 percent Pfizer
has claimed.

At a news conference in Washington, the group and several members of
Congress said the federal government can and should block Pfizer's $160
billion acquisition of Allergan. Pfizer, the world's second-biggest
drugmaker by revenue, says the deal is set to be completed by December.

In a statement to The Associated Press, Pfizer said, "The proposed
combination of Pfizer and Allergan will create a global, R&D-focused
company with the ability to lead in the quest to find cures and treatments
for patients with the most feared diseases and conditions of our time,
such as Alzheimer's disease, Parkinson's disease, cancer and rare genetic
disorders.

"This transaction is not structured to move jobs out of the United States,
where we conduct the majority of our research," Pfizer wrote.

The 28-page report doesn't mention the deal's impact on U.S. jobs. But it
discusses Pfizer's impact on U.S. patients and taxpayers in depth.

It says that in recent years, Pfizer has repeatedly raised prices of its
top-selling drugs, including erectile dysfunction pill Viagra, pain
treatments Lyrica and Celebrex and antibiotic Zyvox. Pfizer raised prices
on those and three other drugs by an average of 39.2 percent from 2013
through 2015 — 23 times overall inflation during that period — and this
year raised prices on about 60 drugs by more than 10 percent on average,
according to the report.

The tax group states that patients in Ireland pay about one-twelfth what
Americans do for Pfizer's seven top drugs. That's because Ireland and
virtually every country except the U.S. sets limits on drug prices, which
are unregulated here. The group suggests Pfizer should cut its drug prices
in the U.S. to what it charges in Ireland, which isn't likely to happen.

Most of those seven drugs have patents that recently expired or will soon.
It's standard procedure for Pfizer and most other drugmakers to jack up
the price of their drugs at that point, to make as much money as possible
before cheaper generic versions flood the market and grab most of the
sales.

The report notes Pfizer benefits from an educated U.S. workforce and
infrastructure here, and makes about 5 percent of its U.S. sales to the
federal government, about $1.01 billion a year on average from 2011
through 2014.

The report also states that Pfizer gets tax credits averaging $118.1
million a year by writing off part of its costs for research and for
manufacturing done within the U.S. It also claims Pfizer got tax breaks
averaging $7 million a year from 2011 through 2014 due to a loophole that
allows it to deduct excess compensation given to top executives in the
form of stock options tied to their performance.

The report is the second one Americans for Taxpayer Fairness has issued
since November criticizing Pfizer's planned inversion. The group is a
coalition that claims 425 members which are national and state
organizations pushing for what it calls "comprehensive, progressive tax
reform."

Ironically, Pfizer and other U.S.-based drugmakers also want Washington to
reform the tax rules. They claim they are at a disadvantage because the
U.S. taxes their profits made both in the U.S. and in other countries,
minus taxes paid to those countries. Drugmakers based in other countries
generally only pay taxes on profits made in each country where they
operate.

But while the U.S. companies complain that the nominal top corporate tax
rate in the U.S. is about 35 percent, most in the pharmaceutical industry
pay a tax rate of around 20 percent, due to various tax credits and other
deductions.



--
Obama increased total debt from $10 trillion to $19 trillion in the six
years he has been in office, and sold out heterosexuals for Hollywood
queer liberal democrat donors.

Barack Obama, reelected by the dumbest voters in the history of the United
States of America. The only American president to deliberately import a
lethal infectious disease from Africa, Ebola.

Loretta Fuddy, killed after she "verified" Obama's phony birth
certificate.

Nancy Pelosi, Democrat criminal, accessory before and after the fact to
improper vetting of Barry Soetoro aka Barack Hussein Obama, a confirmed
felon using SSAN 042-68-4425, belonging to a dead man.

Obama ignored the brutal killing of an American diplomat in Benghazi, then
relieved American military officers who attempted to prevent said murder
in order to cover up his own ineptitude.

Obama continues his muslim goal of disarming America while ObamaCare
increases insurance premiums 300% and leaves millions without health care.

--- news://freenews.netfront.net/ - complaints: ne...@netfront.net ---